Adtalem Global Education Inc (N:ATGE)

Sector:  N/A Industry:  N/A
 
See Regulatory Filings on SEC
Company Contact
Address: 500 W Monroe St Fl 28
CHICAGO IL 60661-3773
Tel: 1-312-9066600
Website: https://www.adtalem.com
IR: See website
<
Key People
Stephen W. Beard
President, Chief Executive Officer, Director
Steven K. Tom
Senior Vice President, Chief Customer Officer
Robert J. Phelan
Chief Financial Officer, Senior Vice President
Michael Betz
President - Walden University
Karen Cox
President - Chamberlain University
Scott Liles
President - Adtalem Medical and Veterinary
Cheryl James
Senior Vice President, Chief Human Resource Officer
Maurice Herrera
Senior Vice President, Chief Marketing Officer
Douglas G. Beck
Senior Vice President, General Counsel, Corporate Secretary and Institutional Support Services
Blake Simpson
Senior Vice President, Chief Communications Officer and Corporate Affairs Officer
   
Business Overview
Adtalem Global Education Inc. is a provider of professional talent to the healthcare industry. The Company operates through three segments: Chamberlain, Walden, and Medical and Veterinary. Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. This segment includes the operations of Chamberlain University (Chamberlain). Walden segment offers more than 100 online certificate, bachelor's, master's, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. Medical and Veterinary segment offers degree and non-degree programs in the medical and veterinary postsecondary education industry. This segment includes the operations of the American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.
Financial Overview
For the nine months ended 31 March 2024, Adtalem Global Education Inc revenues increased 8% to $1.17B. Net income before extraordinary items increased 11% to $87.1M. Revenues reflect Chamberlain segment increase from $149.7M to $466.5M, Walden segment increase from $132.9M to $439M, Medical and Veterinary segment increase from $86.5M to $269.2M, United States segment increase from $282.6M to $905.5M, Barbados, Dominica, St Kitts and St.
Employees: 4,368 as of Jun 30, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $2,930M as of Mar 31, 2024
Annual revenue (TTM): $1,539M as of Mar 31, 2024
EBITDA (TTM): $299.60M as of Mar 31, 2024
Net annual income (TTM): $110.66M as of Mar 31, 2024
Free cash flow (TTM): $238.73M as of Mar 31, 2024
Net Debt Last Fiscal Year: $468.34M as of Mar 31, 2024
Shares outstanding: 37,606,468 as of Apr 26, 2024
Index Membership: S&P 600 Small Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.